Four Colorado Companies Participate at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain in Park City, Utah
Denver, CO (PRWEB) March 4, 2007 -- Four Colorado-based companies are participating at the 2007 Rocky Mountain Bioscience Venture Capital Meeting on the Mountain, March 2-4, at the Park City (UT) Marriott. The announcement is made by Denise Brown, Executive Director, Colorado BioScience Association (CBSA) who says Dorsey & Whitney, lead sponsor of the event, hosts venture capitalists and area companies to learn and explore bioscience opportunities in the Rocky Mountain Region. Co-sponsors include UV Partners, vSpring Capital and Wasatch Venture Fund.
The following Colorado companies are participating in this "invitation-only" event (links to more information about each company are provided):
* Solix Biofuels - http://www.solixbiofuels.com
Solix Biofuels is a developer of massively scaleable photo-bioreactors for the production of biodiesel and other valuable bio-commodities from algae oil. Solix's management team believes it has made important breakthroughs in solving the two of the most important problems of our generation, namely our country's dependence on foreign oil and the acceleration of climate change. Through a partnership with Colorado State University (CSU) and its Engines & Energy Conversion Laboratory, the company has patent pending technology that builds upon 20 years of research (the Aquatic Species Program) originating at the National Renewal Energy Laboratory (NREL).
* Sierra Puenta, Inc. - http://fensters.com/Business%20Plan.htm
Sierra Puente, Inc., is a startup phase biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases of the brain. The company has created multiple reformulations of orally administered medications to be administered into the fluid around the brain for treatment of a platform of diseases including epilepsy, schizophrenia, bipolar disorder, and major depression. Sierra Puente was formed in 2005 to capitalize on the intellectual property of its Scientific Founders at the University of Colorado, Daniel Abrams, MD, Raymond Bunch, MD, Tom Anchordoquy, PhD and Karen Stevens, PhD.
* Apoplogic - http://www.apoplogic.com
ApopLogic Pharmaceuticals, LLC is a startup phase biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products that target apoptotic cell death pathways found in cancers, leukemias and lymphomas. The company was formed in 2006 to capitalize on the intellectual property of its Founding Scientists and University of Colorado Cancer Center members, Richard C. Duke, Ph.D., Donald Bellgrau, Ph.D., Paul A. Bunn, M.D., Daniel Chan, Ph.D., Lajos Gera, Ph.D., Jaime Modiano, D.V.M., Ph.D. and John Stewart, Ph.D. Put most simply, ApopLogic is inducing rapidly dividing cells to commit suicide.
* Microphage - http://www.microphage.com
MicroPhage was founded and incorporated as a Delaware corporation in June 2002 by Jack Wheeler and Kent Voorhees Ph.D., to commercialize a bacterial detection technology licensed from the Colorado School of Mines. This platform technology utilizes a naturally occurring amplification process using lytic bacteriophage. Originally based upon the detection of the bacteriophage specific capsid protein with MALDI-TOF Mass Spectrometry, the company quickly demonstrated the reliability and ease of use of detecting bacteriophage with alternative methods including; lateral flow immunochromatography (LFI), enzyme linked Immunosorbant assay (ELISA), optical immunoassays (OIA) and polymerase chain reaction (PCR).
"Dorsey & Whitney's efforts to bring investors to the Rocky Mountain region to become more familiar with some of our most promising start-ups is greatly appreciated. Their contacts in the investor community will prove to be invaluable to Colorado bioscience companies," Brown explains. "The four Colorado companies that are presenting cover biotech, medical device, and biofuels - a great cross section of the activity here in Colorado."
About Dorsey & Whitney LLP
Dorsey & Whitney LLP is among the largest law firms in the world. With 19 offices strategically located and approximately 650 lawyers and 850 support staff. According to the National Law Journal, which ranks firms by number of lawyers, Dorsey is the 63rd largest U.S. law firm. In The American Lawyer's "AmLaw 100" list, which ranks firms by gross revenues, Dorsey is number 68. Learn more about Dorsey & Whitney at http://www.dorsey.com.
The direct link to Dorsey's "Venture Capital-Emerging Companies" practice area is http://www.dorsey.com/services/service_detail.aspx?page=overview&FlashNavID=services_practice&serviceid=3438003.
About the Colorado BioScience Association
CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 300 members, CBSA actively works to promote the growth of the industry by working for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association http://www.cobioscience.com -- 303.592.4073
Maggie Chamberlin Holben, APR, Absolutely Public Relations http://www.absolutelypr.com -- 303.984.9801
###
Do you want to start a new business? There are many different things that you need to consider with business startup. Planning ahead will help you become very successful in your new business. Helping people start new businesses is something that we are very passionate about. It's the American Dream. Many ventures , internet ventures or otherwise, are faced with the challenging task of raising venture capital. The first part of this process is finding the right venture capital firm (VC). While this may seem simple, it isn't. There are thousands of venture capital firms in the United States alone, and going after the wrong ones is one of the most common reasons why companies fail to raise the capital they need. Find all the information and help you need to find internet venture capital (VC)
Related Articles:
Venture Capital 101
I. WHAT IS VENTURE CAPITAL?
Sabal Medical Receives Second Tranche of Venture Capital
Sabal Medical Inc, a privately held company whose products are helping hospitals deliver medications to their patients more safely and efficiently, is pleased to announce that it has closed on the second tranche of its previously announced institutional investment financing (see press release dated February 19, 2008), led by Nexus Medical Partners of Quincy, MA, and its German affiliate, Medicis Nexus Partners GmbH of Munich.
Punchbowl Lands Venture Capital Funding, Led by Intel Capital
Creators of MyPunchbowl.com (http://www.mypunchbowl.com) secure seed round funding from Intel Capital (http://www.intelcapital.com) and eCoast Angels.
Physware Launches with $2.5M Series A Financing: Leading Venture Capital Firms Support Electronic Design Automation
(EDA) Technology That Delivers
Physware, Inc., a provider of high-speed 3D field solutions for the high-frequency package and board markets, today announced that Madrona Venture Group and WRF Capital have collectively invested $2.5 million in venture funding. This funding will enable Physware (www.physware.com) to accelerate product development and global expansion.
iAmplify Lands Over $6M in Series A Round of Venture Capital
Kodiak Venture Partners funds digital media publishing company.
University Venture Fund Students Score With Two Successful High-Tech Venture Capital Investments: Largest Student-Run Private Equity Fund, with $
A business plan that gives college students a significant role in raising millions of dollars in capital to invest in budding enterprises too dicey for banks and standard capital markets to finance, was a risky proposition for University Venture Fund (UVF) founders in 2001. But today, the students' solid investment successes demonstrate that the concept works.
ClickTale Secures Venture Capital Funding from YL Ventures
Europe's boutique venture capital firm teams up with the pioneer in Web Interaction Analytics (WIA) as the company releases its latest insights on browsing behavior.
AccuDraft Raises $650,000 in Venture Capital
New funding from Smith-Hoffman Capital will help company enhance product line and increase marketplace presence.
Business Financing: A Look at Venture Capital
Raising business finance isn't always easy, and especially so when you've not got enough assets to secure against your ambitious plans In some cases, you're going to have to part with equity
Parature Named ?Hottest Venture Capital Deal? by Northern Virginia Technology Council
NVTC Hot Ticket Awards recognizes Parature for most all-around potential for return on investment.
Investors Choice Southeast Venture Capital Forum to be Held May 10-11 at the Wynfrey Hotel in Birmingham
Submissions will be accepted until March 30 via www.sevencap.org.